Our Projects

OUD in Pregnancy

NeoQIC and MPQC have been working on NAS and opioid use in pregnancy for some time, and we formally joined together in this work last year as PNQIN.  Thus far, most of our attention has focused on the care of the substance-exposed newborn and the family after birth.  Based on great work that has already been done at several centers, we’d like to now dig deeper into collaborative efforts focused on the mother and the care of OUD in pregnancy.  We’re planning a similar model to what MPQC and NeoQIC have used in the past:  hospital and outpatient improvement teams and improvement projects, data sharing, a webinar QI training series, and poster presentations at our PNQIN statewide summits. We are collecting a couple maternal-focused metrics, including one of our primary outcomes of percent of mothers receiving MAT during pregnancy, and we hope to add additional obstetric-focused measures over time. There are a number of infant based measures as well, extending into the year after delivery.  We should be able to use the same REDCap system for all of our data sharing.

Substance Exposed Newborns

The Neonatal Quality Improvement Collaborative of Massachusetts (NeoQIC) and the Massachusetts Perinatal Quality Collaborative (MPQC) are excited to launch a joint statewide quality improvement initiative focused on improving the care of infants and families impacted by perinatal opioid use and neonatal abstinence syndrome. This initiative builds upon years of past improvement work by NeoQIC, MPQC, and hospitals throughout the state, and relies on close collaborations with many state organizations, including the Department of Public Health, the Bureau of Substance Abuse Services, the Department of Children and Families, Early Intervention, and the Health Policy Commission.  

Please reload

A cooperative voluntary program involving Massachusetts maternity facilities and key perinatal stakeholders, designed to promote the sharing of best practices of care.